鼎康生物 Mediaroom - PR Newswire APAC

Search

鼎康生物

Latest News

Chime Biologics and Waterstone Announce a Strategic Partnership to Empower Antibody-Drug Conjugate (ADC) Development and Manufacturing

* Chime Biologics and Waterstone Pharmaceuticals announce a strategic partnership to provide inte...

2024-11-12 21:15 1429

Chime Biologics Achieves ISO 27001 Certification to Strengthen Information Security in the CDMO Industry

WUHAN, China, March 7, 2024 /PRNewswire/ -- Chime Biologics, a leading global CDMO that enables its...

2024-03-07 22:00 1597

Chime Biologics and Hope Medicine Enter Manufacturing Agreement to Speed up the Launch of First-in-class Antibody Drug HMI-115 Targeting Endometriosis and Androgenic Alopecia

* Chime Biologics to support the late-stage clinical study and to provide global commercial manuf...

2023-10-26 22:49 1570

Chime Biologics Enters into a Strategic Cooperation Agreement with Korea Kings Pharm to Accelerate the Biosimilar Launch

* Chime Biologics has entered into a strategic collaboration with Kings Pharm for a biosimilar as...

2023-09-25 20:15 1517

Chime Biologics Announced Global Strategic Cooperation with Panolos Bioscience to Advance Multi-specific Therapeutic Proteins Development

* Chime Biologics and Panolos Bioscience have entered into a global strategic collaboration agree...

2023-09-22 20:15 1670

Chime Biologics Announces Strategic Cooperation with Leads Biolabs and BeiGene to Advance LBL-007 mAb Development and Manufacturing Globally

* Leads Biolabs and Chime Biologics initiate strategic cooperation to accelerate IND application ...

2023-06-30 20:15 2707

Chime Biologics Received Commercial Manufacturing License Indicating the Kick-off into the Era of Commercial Production

* GMP commercial manufacturing license authorized by the National Drug Regulatory Authority, demo...

2022-08-02 20:15 1532

Chime Biologics Announced the Completion of US$190 Million Series A+ Financing to Accelerate Capacity Expansion

WUHAN, China, March 26, 2021 /PRNewswire/ -- Chime Biologics, a China-based, world-class CDMO compa...

2021-03-26 08:00 4346

Chime Biologics Announced the Completion of US$190 Million Series A+ Financing to Accelerate Capacity Expansion

Chime Biologics announces Marc Funk as new Board Director

WUHAN, China, March 22, 2021 /PRNewswire/ -- Chime Biologics is pleased to announce the appointment...

2021-03-22 18:03 1519

Chime Biologics announces Marc Funk as new Board Director